ConductScience.org, home

Trial · NCT00452530

Adverse events222

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherConstipationGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo731,501
otherConstipationGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo771,508
otherVomitingGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo771,501
otherVomitingGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo881,508
otherNauseaGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo1021,501
otherNauseaGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo1201,508
otherDeep vein thrombosisVascular disordersApixiban, 2.5 mg BID Plus Placebo921,501
otherDeep vein thrombosisVascular disordersEnoxaparin, 40 mg QD Plus Placebo1301,508
seriousCreatinine renal clearance decreasedInvestigationsApixiban, 2.5 mg BID Plus Placebo01,501
seriousCreatinine renal clearance decreasedInvestigationsEnoxaparin, 40 mg QD Plus Placebo11,508
seriousDuodenal ulcerGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo11,501
seriousDuodenal ulcerGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo01,508
seriousFistulaMusculoskeletal and connective tissue disordersApixiban, 2.5 mg BID Plus Placebo11,501
seriousFistulaMusculoskeletal and connective tissue disordersEnoxaparin, 40 mg QD Plus Placebo01,508
seriousGastrointestinal haemorrhageGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo01,501
seriousGastrointestinal haemorrhageGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo11,508
seriousHypokinesiaNervous system disordersApixiban, 2.5 mg BID Plus Placebo01,501
seriousHypokinesiaNervous system disordersEnoxaparin, 40 mg QD Plus Placebo11,508
seriousIleus paralyticGastrointestinal disordersApixiban, 2.5 mg BID Plus Placebo01,501
seriousIleus paralyticGastrointestinal disordersEnoxaparin, 40 mg QD Plus Placebo11,508

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00452530/events